Immunological markers for prognostication in cytogenetically normal acute myeloid leukemia
Am J Hematol
.
2015 Dec;90(12):E219-20.
doi: 10.1002/ajh.24179.
Epub 2015 Oct 8.
Authors
Victoria Y Ling
1
2
,
Denise Lee
1
,
Zoe Mcquilten
3
,
Sharon Avery
1
,
Michael Low
1
,
Stephen H Cody
4
,
Trung Nguyen
5
,
Catriona Mclean
5
,
Malgorzata Gorniak
6
,
Andrew Wei
1
2
,
Stephen B Ting
1
2
Affiliations
1
Malignant Haematology & Stem Cell Transplantation Unit, Department of Clinical Haematology, Alfred Health, Melbourne, Australia.
2
Division of Blood Cancers, Leukaemia & Stem Cell Research, Australian Centre for Blood Diseases, Monash University, Melbourne, Australia.
3
Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Australia.
4
Monash Micro Imaging, Monash University, Melbourne, Australia.
5
Department of Anatomical Pathology, Alfred Health, Melbourne, Australia.
6
Department of Laboratory Haematology, Alfred Health, Melbourne, Australia.
PMID:
26317398
DOI:
10.1002/ajh.24179
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
MeSH terms
Cytogenetics / methods*
Humans
Leukemia, Myeloid, Acute / immunology*
Leukemia, Myeloid, Acute / pathology
Prognosis